Life sciences stories
Businesses could cut weeks from app projects as Netcall's new AI tools automate process mapping, search and specification drafting.
Drug discovery teams can now outsource industrial-scale CRISPR screening in human cells as the Cambridge biotech expands its service offer.
The shortlist highlights UK startups in biotech, energy, health and AI as investors and buyers look for scalable technology beyond Cambridge.
Firms face new disclosure duties as Brussels starts policing when users are interacting with AI and how generated content is labelled.
UK businesses drew GBP £14.4 billion in equity funding in the first half of 2026, as London still dominated despite sharp regional gains.
Many firms have scaled back research, hiring and projects after HMRC tightened the UK's R&D tax relief rules, a survey finds.
A bespoke office server now cuts a 70-slide medical presentation editing job from two and a half days to 15 minutes, keeping pharma data secure.
The deal gives the engineering services group fresh firepower to target bigger data centre and infrastructure projects across the UK and Europe.
Healthcare providers could gain better data sharing and AI-driven administration as the tie-up targets fragmented systems across several major markets.
Rising demand for board-level hires in the UK and US has prompted the search firm to expand specialist coverage after client demand jumped 120%.
Cheaper, faster agent workflows are the aim as Nvidia's new open model and routing library target multi-model AI systems.
The HEOR tech firm is using generative AI to cut approval analyses from years to weeks, reshaping launch decisions and regulator responses.
The expansion signals Cognizant's push to turn AI trials into production work for clients amid tighter scrutiny of governance and risk.
The new model now underpins Claude Max at the same price as Opus 4.8, with stronger coding and research performance, Anthropic said.
Enterprise demand for AI projects is driving Acceldata to expand in Europe, as firms seek sovereignty controls without lengthy data migrations.
Better process visibility could help the Danish drugmaker shave 12 months or more off development, bringing medicines to patients sooner.
Businesses using AI face growing pressure to prove answers are accurate and authorised, as Mithra AI adds cryptographic checks to enterprise data.
Pharmaceutical groups could cut safety processing costs by 30% as the platform automates regulated drug development tasks under human oversight.
Free access to ChatGPT will reach 10,000 Australian researchers first, as OpenAI targets science and maths work at universities.
The shortlist spans software, biotech and retail, highlighting the breadth of New Zealand firms vying for EY's 2026 entrepreneur prize.